Work

The Mainstreaming Addiction Treatment Act and Pharmacist-Prescribed Buprenorphine

Year: 2025

Type: article

Study design: Observational Study

Abstract: This study examines the impact of the MAT Act on trends in pharmacist-prescribed buprenorphine from US retail pharmacies from 2019 to 2024.

Source: JAMA

DOI: 10.1001/jama.2025.7151

Authors: Emmy L. Tran, S. Michaela Rikard, Gery P. Guy, Christina A. Mikosz

Institutions: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health

Award: G7543494365

OpenAlex ID: W4411329746

FWCI: 3.397

Cites: 4

Cited by: 4

Related to: 10